awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39010098-109F4459-B489-4F52-93EF-D5491245A549
Q39010098-109F4459-B489-4F52-93EF-D5491245A549
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39010098-109F4459-B489-4F52-93EF-D5491245A549
New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails?
P2860
Q39010098-109F4459-B489-4F52-93EF-D5491245A549
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39010098-109F4459-B489-4F52-93EF-D5491245A549
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c1514b2d3ea29d45171e0ced28a49de9f6739d97
P2860
Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial.